Please use this identifier to cite or link to this item: https://doi.org/10.1136/heartjnl-2013-305471
Title: Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy
Authors: Ismail T.F.
Jabbour A.
Gulati A.
Mallorie A.
Raza S.
Cowling T.E.
Das B.
Khwaja J.
Alpendurada F.D.
Wage R.
Roughton M.
McKenna W.J.
Moon J.C.
Varnava A.
Shakespeare C.
Cowie M.R.
Cook S.A. 
Elliott P.
O'Hanlon R.
Pennell D.J.
Prasad S.K.
Issue Date: 2014
Publisher: BMJ Publishing Group
Citation: Ismail T.F., Jabbour A., Gulati A., Mallorie A., Raza S., Cowling T.E., Das B., Khwaja J., Alpendurada F.D., Wage R., Roughton M., McKenna W.J., Moon J.C., Varnava A., Shakespeare C., Cowie M.R., Cook S.A., Elliott P., O'Hanlon R., Pennell D.J., Prasad S.K. (2014). Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy. Heart 100 (23) : 1851-1858. ScholarBank@NUS Repository. https://doi.org/10.1136/heartjnl-2013-305471
Abstract: Objective: Myocardial fibrosis identified by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) in patients with hypertrophic cardiomyopathy (HCM) is associated with adverse cardiovascular events, but its value as an independent risk factor for sudden cardiac death (SCD) is unknown. We investigated the role of LGE-CMR in the risk stratification of HCM. Methods: We conducted a prospective cohort study in a tertiary referral centre. Consecutive patients with HCM (n=711, median age 56.3 years, IQR 46.7-66.6; 70.0% male) underwent LGE-CMR and were followed for a median 3.5 years. The primary end point was SCD or aborted SCD. Results: Overall, 471 patients (66.2%) had myocardial fibrosis (median 5.9% of left ventricular mass, IQR: 2.2-13.3). Twenty-two (3.1%) reached the primary end point. The extent but not the presence of fibrosis was a significant univariable predictor of the primary end point (HR per 5% LGE: 1.24, 95% CI 1.06 to 1.45; p=0.007 and HR for LGE: 2.69, 95% CI 0.91 to 7.97; p=0.073, respectively). However, on multivariable analysis, only LV-EF remained statistically significant (HR: 0.92, 95% CI 0.89 to 0.95; p<0.001). For the secondary outcome of cardiovascular mortality/aborted SCD, the presence and the amount of fibrosis were significant predictors on univariable but not multivariable analysis after adjusting for LV-EF and non-sustained ventricular tachycardia. Conclusions: The amount of myocardial fibrosis was a strong univariable predictor of SCD risk. However, this effect was not maintained after adjusting for LV-EF. Further work is required to elucidate the interrelationship between fibrosis and traditional predictors of outcome in HCM. ? 2014, BMJ Publishing Group. All rights reserved.
Source Title: Heart
URI: http://scholarbank.nus.edu.sg/handle/10635/150851
ISSN: 13556037
DOI: 10.1136/heartjnl-2013-305471
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
1851.full.pdf2.43 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

73
checked on Apr 19, 2019

Page view(s)

8
checked on Apr 20, 2019

Download(s)

2
checked on Apr 20, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.